Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI115071

Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.

S Amselem, M L Sobrier, P Duquesnoy, R Rappaport, M C Postel-Vinay, M Gourmelen, B Dallapiccola, and M Goossens

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Amselem, S. in: PubMed | Google Scholar

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Sobrier, M. in: PubMed | Google Scholar

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Duquesnoy, P. in: PubMed | Google Scholar

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Rappaport, R. in: PubMed | Google Scholar

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Postel-Vinay, M. in: PubMed | Google Scholar

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Gourmelen, M. in: PubMed | Google Scholar

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Dallapiccola, B. in: PubMed | Google Scholar

Service de Biochimie, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.

Find articles by Goossens, M. in: PubMed | Google Scholar

Published March 1, 1991 - More info

Published in Volume 87, Issue 3 on March 1, 1991
J Clin Invest. 1991;87(3):1098–1102. https://doi.org/10.1172/JCI115071.
© 1991 The American Society for Clinical Investigation
Published March 1, 1991 - Version history
View PDF
Abstract

In addition to its classical effects on growth, growth hormone (GH) has been shown to have a number of other actions, all of which are initiated by an interaction with specific high affinity receptors present in a variety of tissues. Purification of a rabbit liver protein via its ability to bind GH has allowed the isolation of a cDNA encoding a putative human growth hormone receptor that belongs to a new class of transmembrane receptors. We have previously shown that this putative growth hormone receptor gene is genetically linked to Laron dwarfism, a rare autosomal recessive syndrome caused by target resistance to GH. Nevertheless, the inability to express the corresponding full-length coding sequence and the lack of a test for growth-promoting function have hampered a direct confirmation of its role in growth. We have now identified three nonsense mutations within this growth hormone receptor gene, lying at positions corresponding to the amino terminal extremity and causing a truncation of the molecule, thereby deleting a large portion of both the GH binding domain and the full transmembrane and intracellular domains. Three independent patients with Laron dwarfism born of consanguineous parents were homozygous for these defects. Two defects were identical and consisted of a CG to TG transition. Not only do these results confirm the growth-promoting activity of this receptor but they also suggest that CpG doublets may represent hot spots for mutations in the growth hormone receptor gene that are responsible for hereditary dwarfism.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1098
page 1098
icon of scanned page 1099
page 1099
icon of scanned page 1100
page 1100
icon of scanned page 1101
page 1101
icon of scanned page 1102
page 1102
Version history
  • Version 1 (March 1, 1991): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts